## **Core Concept**
The question tests understanding of the impact of a drug that reduces mortality but does not cure a disease. This type of drug typically manages chronic conditions, improving survival rates but not eliminating the disease. The long-term effect of such a drug can lead to an accumulation of patients living with the disease.

## **Why the Correct Answer is Right**
A drug that reduces mortality but does not cure a disease improves survival rates, leading to an increased prevalence of the disease in the population over time. This is because patients are living longer with the disease but not being cured. This scenario often applies to the management of chronic diseases like **HIV/AIDS**, **hypertension**, or **diabetes**, where treatment improves life expectancy but does not offer a cure.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately reflect the outcome of a drug that reduces mortality without curing a disease.
- **Option B:** This option is incorrect as it does not specify what "B" refers to, making it impossible to assess its accuracy.
- **Option C:** Without specifying what "C" represents, it's impossible to evaluate its correctness.
- **Option D:** This option is incorrect because, similar to A, B, and C, without the actual content, we cannot assess its validity.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that drugs which manage chronic diseases without offering a cure can lead to an increased prevalence of the disease. This is a critical concept in **public health** and **pharmacology**, as it highlights the importance of ongoing management and potential future treatments aimed at cure or more effective control.

## **Correct Answer:** . Increased prevalence of the disease.